公司资料
Cyclacel 股价、新闻与催化剂
- 股票代码:
- CYCC
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United Kingdom and traded in the U
股价为何变动
Current closing-price context is not available for CYCC.
公司概览
业务概览
Cyclacel Pharmaceuticals was an oncology-focused company working on cell-cycle and cancer biology before becoming a legacy ticker. Its story centered on using small-molecule mechanisms to attack difficult tumors.
所在地与行业分类
Cyclacel was headquartered in the United Kingdom and traded in the U.S. market. It sat in small-cap oncology biotechnology.
商业模式特征
The company depended on clinical progress, capital management, and the ability to keep a narrow pipeline advancing. Investors historically tracked readouts and financing needs.
生物医药行业定位
Cyclacel belongs to the historical small-cap oncology biotech bucket. Like many cancer-drug developers, its story was defined by a narrow pipeline and high execution risk.
未来催化剂
- Cyclacel is a legacy / closeout story now, so the catalysts are any remaining strategic or asset-resolution update rather than a fresh oncology milestone. Investors are watching residual value.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。